OverviewSuggest Edit

Mentice is a company engaged in the development of software and hardware simulation solutions for endovascular therapies. These solutions help healthcare professionals acquire, retain, and enhance their procedural skills. The company also provides training, troubleshooting, and remote access support services.
TypePublic
Founded1999
HQGöteborg, SE
Websitementice.com

Latest Updates

Employees (est.) (Jun 2021)100(+3%)
Revenue (FY, 2020)KR137.5 M(-7%)
Share Price (Nov 2021)KR118.5(+7%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Mentice

Göran Malmberg

Göran Malmberg

Group CEO & President
Henrik Storm

Henrik Storm

Chief Technology Officer
Matar Dakhil

Matar Dakhil

Executive Vice President, Global Medical Device Industry
Kjell Asserlind

Kjell Asserlind

Vice President & General Manager, EMEA/CIS
Martin Harris

Martin Harris

Vice President, Marketing & Business Development
Maria Thilmann

Maria Thilmann

Vice President, Human Resources
Show more

Mentice Office Locations

Mentice has offices in Göteborg, Chicago, Greenwood Village, Beijing and in 1 other location
Göteborg, SE (HQ)
Odinsgatan 10
Beijing, CN
3-109 BLDG E16, No.13 Langfang, ToutiaoXicheng District
Tokyo, JP
1-10-3-901, Roppongi, Minato – ku
Chicago, IL, US
820 W Jackson Blvd #250
Greenwood Village, CO, US
5690 DTC Blvd #370E
Show all (5)

Mentice Financials and Metrics

Mentice Revenue

Embed Graph
View revenue for all periods
Mentice's revenue was reported to be kr137.5 m in FY, 2020 which is a 7.9% decrease from the previous period.
SEK

Revenue (Q2, 2021)

46.4m

Gross profit (Q2, 2021)

37.0m

Gross profit margin (Q2, 2021), %

79.8%

Net income (Q2, 2021)

(5.4m)

EBIT (Q2, 2021)

(5.1m)

Market capitalization (10-Nov-2021)

2.9b

Closing stock price (10-Nov-2021)

118.5

Cash (30-Jun-2021)

26.3m

EV

2.9b
Mentice's current market capitalization is kr2.9 b.
Annual
SEKFY, 2018FY, 2019FY, 2020

Revenue

157.0m149.4m137.5m

Revenue growth, %

(5%)(8%)

Cost of goods sold

29.5m22.5m33.4m

Gross profit

127.6m126.9m104.1m
Quarterly
SEKQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021

Revenue

27.5m32.4m29.3m33.8m24.3m33.4m32.3m46.4m

Cost of goods sold

4.2m5.9m3.2m5.1m6.1m5.3m6.4m9.4m

Gross profit

23.3m26.5m26.1m28.6m18.2m28.2m25.9m37.0m

Gross profit Margin, %

85%82%89%85%75%84%80%80%
Annual
SEKFY, 2018FY, 2019FY, 2020

Cash

17.8m48.0m48.8m

Accounts Receivable

42.3m37.4m29.5m

Inventories

5.0m9.3m5.8m

Current Assets

81.1m115.1m104.1m
Quarterly
SEKQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021

Cash

11.4m84.9m63.1m43.0m49.3m35.7m27.8m26.3m

Accounts Receivable

35.4m29.0m26.3m47.0m26.7m32.8m39.5m34.2m

Inventories

6.4m4.4m5.5m8.8m7.3m5.2m6.1m6.0m

Current Assets

62.1m127.3m104.2m110.4m94.9m89.8m96.5m92.8m
Annual
SEKFY, 2018FY, 2019FY, 2020

Inventories

1.7m(6.0m)3.0m

Cash From Operating Activities

16.0m(37.3m)30.5m

Purchases of PP&E

(2.5m)(3.8m)(3.3m)

Cash From Investing Activities

(12.4m)(4.0m)(25.0m)
Quarterly
SEKQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021

Inventories

(1.4m)(68.0k)(1.3m)958.0k2.1m4.0m(213.0k)(194.0k)

Cash From Operating Activities

(3.7m)(4.5m)(20.6m)1.5m16.7m10.5m(13.1m)(4.8m)

Purchases of PP&E

(116.0k)(355.0k)(2.2m)(92.0k)(1.3m)(2.0m)(2.4m)(5.2m)

Cash From Investing Activities

(1.6m)(4.3m)(8.0m)(5.5m)(13.2m)(18.9m)(6.6m)(15.7m)
SEKFY, 2018

Financial Leverage

2 x
Show all financial metrics

Mentice Operating Metrics

FY, 2018Q1, 2019Q2, 2019Q3, 2019FY, 2019Q1, 2020Q2, 2020Q3, 2020FY, 2020Q1, 2021Q2, 2021

Order Book

kr51.4 mkr47 mkr50.1 mkr33.9 mkr41.3 mkr43 mkr66.4 mkr72.9 mkr67.9 m

Order Intake

kr174.25 mkr25.1 mkr34.9 mkr24.4 mkr139.27 mkr32.5 mkr28.4 mkr34.6 mkr168.64 mkr39.9 mkr40.2 m
Show all operating metrics

Mentice Acquisitions / Subsidiaries

Company NameDateDeal Size
MyIRlogOctober 08, 2020
Vascular SimulationsOctober 01, 2020
MSC - Medical ProductsDecember 20, 2017
Mentice Inc
Mentice International Trading (Beijing) Co., Ltd
Mentice KK

Mentice Revenue Breakdown

Embed Graph

Mentice revenue breakdown by business segment: 25.3% from Teaching Entities, 73.5% from Medical Device Industry and 1.2% from Other

Mentice revenue breakdown by geographic segment: 43.0% from Americas, 25.8% from APAC and 31.3% from EMEA

Mentice Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

SecurityScorecard logo

Mentice Online and Social Media Presence

Embed Graph

Mentice News and Updates

Mentice receives order of total SEK 7.0 million from ABBOTT

STOCKHOLM, Oct. 18, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, has through its fully owned subsidiary Mentice Inc entered into an agreement with ABBOTT Inc. to provide...

Nomination committee has been appointed for Mentice AB (publ) Annual General Meeting 2022

STOCKHOLM, Sept. 30, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, announces that the nomination committee for the company's Annual General Meeting 2022 has been appointed....

Mentice appoints Pontus Appelqvist as Vice President and GM for Asia Pacific

STOCKHOLM, April 15, 2021 /PRNewswire/ -- Mentice AB (STO: MNTC), a leading supplier of high-tech solutions for simulation in the medical sector, with a focus on endovascular procedures, today announced the appointment of Pontus Appelqvist as Vice President and General Manager for Asia...

Mentice to Acquire Vascular Simulations

STOCKHOLM, Oct. 1, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC) today signed a definitive agreement to acquire the New York-based medical technology company Vascular Simulations (VSI), a world-leading provider of replication solutions allowing endovascular procedures to be performed by...

Mentice Blogs

Mentice Introduces Today Subscription-Based Pricing for its Endovascular-Simulation Training Software

Introduction to Health Systems brings transparency, flexibility and predictability; opens new opportunities for clinicians to rapidly deploy simulation training for new and existing endovascular therapies.

Mentice Frequently Asked Questions

  • When was Mentice founded?

    Mentice was founded in 1999.

  • Who are Mentice key executives?

    Mentice's key executives are Göran Malmberg, Henrik Storm and Matar Dakhil.

  • How many employees does Mentice have?

    Mentice has 100 employees.

  • What is Mentice revenue?

    Latest Mentice annual revenue is kr137.5 m.

  • What is Mentice revenue per employee?

    Latest Mentice revenue per employee is kr1.4 m.

  • Who are Mentice competitors?

    Competitors of Mentice include Surgical Science, VirtaMed and Gaumard.

  • Where is Mentice headquarters?

    Mentice headquarters is located at Odinsgatan 10, Göteborg.

  • Where are Mentice offices?

    Mentice has offices in Göteborg, Chicago, Greenwood Village, Beijing and in 1 other location.

  • How many offices does Mentice have?

    Mentice has 5 offices.